Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 18Non-Muscle Invasive Bladder Neoplasms 12Carcinoma, Transitional Cell 11Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Anus Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Urologic Neoplasms 2Urologic Diseases 2Urogenital Neoplasms 2Urinary Bladder Diseases 2Stomach Neoplasms 2Neoplasms by Site 2Colonic Neoplasms 2Anal Canal Carcinoma 2Uterine Cervical Neoplasms 1Urogenital Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mycobacterium Infections 1

Interventions

Radiotherapy 3Fluorouracil 3Cisplatin 3Nivolumab 2Mitomycin 2X-Rays 1Watchful Waiting 1Taxes 1Specimen Handling 1Sigmoidoscopy 1Radiation 1Proctoscopy 1Phantoms, Imaging 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1Colonoscopy 1Chemoradiotherapy 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Anal Canal Carcinoma × Mitomycin × Clear all
NCT00003596 2017-01-04

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
682 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00025090 2013-08-26

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

National Cancer Institute (NCI)

Phase 3 Completed
600 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡